Abstract
Hypercalcaemia is often an incidental finding during biochemical investigation, being found in 1. 1% of the general population 1 and 3-6% of patients in hospital. 2 The most common cause is primary hyperparathyroidism. Ten per cent of patients with sarcoidosis have hypercalcaemia, but hypercalciuria is much more common. 3 It is therefore possible that β antagonists may be given to some patients with unsuspected disturbances in their calcium metabolism. I report on the effects of the β 1 antagonist atenolol on the calcium balance of two patients.
Original language | English (US) |
---|---|
Pages (from-to) | 1324-1325 |
Number of pages | 2 |
Journal | British Medical Journal (Clinical research ed.) |
Volume | 294 |
Issue number | 6583 |
DOIs | |
State | Published - May 23 1987 |
All Science Journal Classification (ASJC) codes
- General Medicine